Loading...
XNAS
ALTS
Market cap82mUSD
May 19, Last price  
6.80USD
1D
0.00%
1Q
-7.67%
Jan 2017
21.43%
IPO
-76.39%
Name

Janone Inc

Chart & Performance

D1W1MN
XNAS:ALTS chart
P/E
—
P/S
6.60
EPS
—
Div Yield, %
—
Shrs. gr., 5y
44.60%
Rev. gr., 5y
-18.61%
Revenues
13m
74,893,00077,790,000100,765,000110,971,000101,269,000108,162,000126,669,000114,313,000129,061,000130,930,000111,839,000103,589,00041,544,00036,794,00035,097,00033,867,00040,022,00039,611,000012,532,000
Net income
-6m
L-68.87%
-933,000-1,409,0002,539,000360,000-3,338,0002,009,0004,461,000-3,852,0003,318,000771,000-2,717,000-1,451,000118,000-5,608,000-11,964,000-8,498,000-16,887,0003,589,000-20,060,000-6,245,000
CFO
2m
+21.46%
-2,149,000-10,000-6,248,0001,649,0001,336,0003,475,0001,376,000551,0001,740,0003,595,000-3,409,0002,659,0001,226,0004,145,000-3,510,000-617,000-5,292,000-3,056,0001,463,0001,777,000
Earnings
Aug 18, 2025

Profile

JanOne Inc., a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of pain and addiction. It operates through three segments: Biotechnology, Recycling, and Technology. The company's lead product candidate is JAN101, a patented oral and sustained release pharmaceutical composition of sodium nitrite that targets poor blood flow to the extremities in patients with diabetes or peripheral artery disease to treat pain. It also provides turnkey appliance recycling and replacement services for utilities and other sponsors of energy efficiency programs; and designs, develops, and sells cellular transceiver modules and associated wireless services. The company was formerly known as Appliance Recycling Centers of America, Inc. and changed its name to JanOne Inc. in September 2019. JanOne Inc. was founded in 1976 and is headquartered in Las Vegas, Nevada.
URL
https://janone.com/
IPO date
Feb 22, 2006
Employees
199
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122022‑002021‑002019‑122018‑122017‑122016‑122016‑00
Income
Revenues
12,532
 
39,611
16.96%
Cost of revenue
6,238
1,500
31,992
Unusual Expense (Income)
NOPBT
6,294
(1,500)
7,619
NOPBT Margin
50.22%
19.23%
Operating Taxes
(3,041)
(429)
(6,671)
Tax Rate
NOPAT
9,335
(1,071)
14,290
Net income
(6,245)
-68.87%
(20,060)
18.79%
3,589
-142.23%
Dividends
Dividend yield
Proceeds from repurchase of equity
851
1,051
BB yield
-1.64%
-47.28%
Debt
Debt current
1,385
6,692
Long-term debt
11,806
707
11,208
Deferred revenue
Other long-term liabilities
3,964
34
46
Net debt
6,014
416
17,470
Cash flow
Cash from operating activities
1,777
1,463
(3,056)
CAPEX
(1,509)
Cash from investing activities
5,853
(155)
(1,509)
Cash from financing activities
6,093
(1,435)
3,979
FCF
6,141
1,842
9,141
Balance
Cash
7,177
5
115
Long term investments
286
315
Excess cash
6,550
291
Stockholders' equity
(46,710)
(50,631)
(28,931)
Invested Capital
88,553
62,574
51,759
ROIC
12.35%
31.00%
ROCE
14.68%
33.09%
EV
Common stock shares outstanding
11,148
4,005
3,150
Price
4.65
737.84%
0.56
-86.43%
1.37
-71.98%
Market cap
51,840
2,232.05%
2,223
-79.56%
4,316
-52.35%
EV
70,331
17,149
36,296
EBITDA
9,728
8,231
EV/EBITDA
7.23
4.41
Interest
879
489
Interest/NOPBT
13.97%
6.42%